| Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial … AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, ... The Lancet 389 (10068), 505-518, 2017 | 1054 | 2017 |
| Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial AM Henao-Restrepo, IM Longini, M Egger, NE Dean, WJ Edmunds, ... The Lancet 386 (9996), 857-866, 2015 | 879 | 2015 |
| Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient V Eldholm, G Norheim, B von der Lippe, W Kinander, UR Dahle, ... Genome biology 15 (11), 1-11, 2014 | 181 | 2014 |
| Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes P Nicolas, G Norheim, E Garnotel, S Djibo, DA Caugant Journal of clinical microbiology 43 (10), 5129-5135, 2005 | 136 | 2005 |
| Emergence of serogroup X meningococcal disease in Africa: need for a vaccine O Xie, AJ Pollard, JE Mueller, G Norheim Vaccine 31 (27), 2852-2861, 2013 | 133 | 2013 |
| The concept of “tailor-made”, protein-based, outer membrane vesicle vaccines against meningococcal disease J Holst, B Feiring, LM Næss, G Norheim, P Kristiansen, EA Høiby, K Bryn, ... Vaccine 23 (17-18), 2202-2205, 2005 | 125 | 2005 |
| The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola Ebola ça Suffit Ring Vaccination Trial Consortium BMJ: British Medical Journal 351, h3740, 2015 | 122 | 2015 |
| Mycobacterium tuberculosis lineage 7 strains are associated with prolonged patient delay in seeking treatment for pulmonary tuberculosis in Amhara Region, Ethiopia SA Yimer, G Norheim, A Namouchi, ED Zegeye, W Kinander, T Tønjum, ... Journal of clinical microbiology 53 (4), 1301-1309, 2015 | 93 | 2015 |
| Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X F Micoli, MR Romano, M Tontini, E Cappelletti, M Gavini, D Proietti, ... Proceedings of the National Academy of Sciences 110 (47), 19077-19082, 2013 | 75 | 2013 |
| Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis G Norheim, A Aase, DA Caugant, EA Høiby, E Fritzsønn, T Tangen, ... Vaccine 23 (29), 3762-3774, 2005 | 51 | 2005 |
| Developing vaccines against epidemic-prone emerging infectious diseases V Bernasconi, PA Kristiansen, M Whelan, RG Román, A Bettis, SA Yimer, ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 63 (1), 65-73, 2020 | 43 | 2020 |
| A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial L Marsay, C Dold, CA Green, CS Rollier, G Norheim, M Sadarangani, ... Journal of Infection 71 (3), 326-337, 2015 | 42 | 2015 |
| Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies O Xie, B Bolgiano, F Gao, K Lockyer, C Swann, C Jones, I Delrieu, ... Vaccine 30 (40), 5812-5823, 2012 | 42 | 2012 |
| Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989 G Norheim, E Rosenqvist, A Aseffa, MA Yassin, G Mengistu, A Kassu, ... Journal of clinical microbiology 44 (3), 861-871, 2006 | 42 | 2006 |
| Rift valley fever: diagnostic challenges and investment needs for vaccine development V Petrova, P Kristiansen, G Norheim, SA Yimer BMJ Global Health 5 (8), e002694, 2020 | 39 | 2020 |
| Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex AG Birhanu, SA Yimer, S Kalayou, T Riaz, ED Zegeye, C Holm-Hansen, ... Scientific reports 9 (1), 1-15, 2019 | 38 | 2019 |
| Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial … AG Birhanu, SA Yimer, C Holm-Hansen, G Norheim, A Aseffa, M Abebe, ... Journal of proteome research 16 (11), 4045-4059, 2017 | 34 | 2017 |
| An Outer Membrane Vesicle Vaccine for Prevention of Serogroup A and W‐135 Meningococcal Disease in the African Meningitis Belt G Norheim, G Tunheim, LM Naess, PA Kristiansen, DA Caugant, ... Scandinavian journal of immunology 76 (2), 99-107, 2012 | 33 | 2012 |
| Tuberculosis outbreak in an educational institution in Norway G Norheim, S Seterelv, TM Arnesen, AT Mengshoel, T Tønjum, ... Journal of clinical microbiology 55 (5), 1327-1333, 2017 | 31 | 2017 |
| Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens JC Nagaputra, CS Rollier, M Sadarangani, JC Hoe, OH Mehta, ... Clinical and Vaccine Immunology 21 (2), 234-242, 2014 | 29 | 2014 |
Dominique CaugantProfessorVerified email at fhi.no
